All posts related to "medication"

AS it Goes – Bridging the Patient-Doctor Divide

The doctor is listeningA checkup appointment at my rheumatologist (doctor who specializes in arthritis) always leads to some interesting discussions. Most of the time I try to “research” a topic beforehand, so that I am armed with the latest background information on whatever are my most pressing concerns at the time. When I launch into my questions (I always have a list written out), I have a better-than-even chance of holding a meaningful conversation with my rheumy. In turn, I get more out of the conversation instead of returning home with questions that even Google cannot answer. Understanding what he is really saying provides me with the sense that I am in control of my ankylosing spondylitis (AS), and not the other way around (AS controlling me?) Continue reading

AS it Goes – The Debate over NSAIDs

Pain relief (and NSAIDs)

Photo courtesy of David Castillo Dominici | FreeDigitalPhotos.net

The long-term usage of non-steroidal anti-inflammatories (NSAIDs) has always concerned me. Through the years I have taken different types of NSAIDs for varying periods. These NSAIDs even included (for a short time) VIOXX, which was pulled off the shelves in 2004 after studies confirmed that it increased the risk of heart attack and stroke. For many years I have taken diclofenac, which now researchers also believe carries a high cardiovascular risk, especially for people with a history of heart disease or other risk factors such as diabetes or high cholesterol. Continue reading

Call for patient organization input

Stickman with megaphone calling for patient organization inputCall for patient organization input on certolizumab pegol (Cimzia®) for psoriatic arthritis

Do you have psoriatic arthritis or care for someone who does? We need your valuable input.

The Common Drug Review (CDR) is currently welcoming patients and their caregivers to provide input to patient organizations on the manufacturer’s submission for certolizumab pegol (Cimzia®) for the treatment of psoriatic arthritis (PsA). Certolizumab pegol is indicated for use in combination with methotrexate for reducing signs and symptoms and inhibiting the progression of structural damage as assessed by X-ray, in adult patients with moderately to severely active psoriatic arthritis who have failed one or more disease-modifying anti-rheumatic drugs (DMARDs). Continue reading

One Needle, Only One Time

Injection needle“One needle, only one time.” This statement may seem obvious in the context of any medical practice but as guest author on the Centers for Disease Control blog Dr. John O’Keefe notes in his article, Moving the Needle to Safe Dentistry, that rule, alarmingly, is not always followed.

As a result, the “One & Only Campaign” was created to raise awareness among patients and healthcare providers about safe injection practices. Led by the Centers for Disease Control and Prevention (CDC) and the Safe Injection Practices Coalition (SIPC), the campaign aims to eradicate outbreaks resulting from unsafe injection practices.

Dr. O’Keefe is a dentist and board chairman for the Organization for Safety, Asepsis and Prevention (OSAP), which is the dental sector’s premier organization dedicated to infection prevention and control. OSAP, disappointed when it discovered that unsafe practices in a U.S. dental setting led to the first documented patient-to-patient case of hepatitis C last year, has joined forces with the CDC and SIPC. Click here to read the full article.

Research shows arthritis medication may slow Alzheimer’s

Brain xrayA recent research from the University of Southampton shows that the arthritis medication, etanarcept (Enbrel®), may slow Alzheimer’s disease. The research was presented at the Alzheimer’s Association International Conference in Denmark last week.

In the small control study, a group of 41 patients exhibiting mild or moderate Alzheimer’s was given either the anti-inflammatory medication etanercept or a placebo every week over a period of six months.

Researchers monitored memory function in patients and found that the efficiency of day-to-day activities and behaviour and the symptoms of those who had taken etanercept did not get any worse. In comparison, the placebo group showed signs of decline in memory function.

In an interview with the Daily Mail, lead researcher, Professor Clive Holmes, said:

Continue reading

AS it Goes – Too Good to be True?

Symbol of a target with and arrow and the word "promo"

Photo courtesy of Stuart Miles with FreeDigitalPhotos.net

Last week, my computer mouse inadvertently hovered over some advertising scrolling along the screen and I was instantly transported to another website.

This is not the first time this has happened, but before I became involved in an investment pitch or a cure for belly fat (both of which I probably could use), I warned myself to be remain vigilant and then repeatedly hit the “back” button until I was safely back on the terra firma of my home page. Continue reading